• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球膀胱癌的当前及未来负担

The present and future burden of urinary bladder cancer in the world.

作者信息

Ploeg Martine, Aben Katja K H, Kiemeney Lambertus A

机构信息

Department of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands.

出版信息

World J Urol. 2009 Jun;27(3):289-93. doi: 10.1007/s00345-009-0383-3. Epub 2009 Feb 15.

DOI:10.1007/s00345-009-0383-3
PMID:19219610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2694323/
Abstract

Urinary bladder cancer (UBC) is a common disease worldwide. At any point in time 2.7 million people have a history of UBC. The incidence of UBC varies over the world with highest rates in developed communities. But the burden of UBC will increase in less developed areas of the world. These changes can be attributed to global changes in exposure to risk factors for UBC and growth and aging of the world population.

摘要

膀胱癌(UBC)是一种全球范围内的常见疾病。在任何时间点,都有270万人有膀胱癌病史。膀胱癌的发病率在全球各地有所不同,在发达地区发病率最高。但在世界较不发达地区,膀胱癌的负担将会增加。这些变化可归因于全球范围内膀胱癌风险因素暴露情况的变化以及世界人口的增长和老龄化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/589e/2694323/997a58a505e4/345_2009_383_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/589e/2694323/41e52968bd74/345_2009_383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/589e/2694323/997a58a505e4/345_2009_383_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/589e/2694323/41e52968bd74/345_2009_383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/589e/2694323/997a58a505e4/345_2009_383_Fig3_HTML.jpg

相似文献

1
The present and future burden of urinary bladder cancer in the world.全球膀胱癌的当前及未来负担
World J Urol. 2009 Jun;27(3):289-93. doi: 10.1007/s00345-009-0383-3. Epub 2009 Feb 15.
2
The global burden of urinary bladder cancer: an update.全球膀胱癌负担:更新。
World J Urol. 2020 Aug;38(8):1895-1904. doi: 10.1007/s00345-019-02984-4. Epub 2019 Nov 1.
3
Epidemiology of Bladder Cancer in the Arab World: 2019 Global Burden of Disease Data.阿拉伯世界膀胱癌的流行病学:2019 年全球疾病负担数据。
Asian Pac J Cancer Prev. 2022 Sep 1;23(9):2907-2919. doi: 10.31557/APJCP.2022.23.9.2907.
4
The future burden of kidney and bladder cancers preventable by behavior modification in Australia: A pooled cohort study.澳大利亚通过行为改变预防肾脏和膀胱癌的未来负担:一项汇总队列研究。
Int J Cancer. 2020 Feb 1;146(3):874-883. doi: 10.1002/ijc.32420. Epub 2019 Jun 12.
5
Global Burden of Urologic Cancers, 1990-2013.全球泌尿生殖系统癌症负担,1990-2013 年。
Eur Urol. 2017 Mar;71(3):437-446. doi: 10.1016/j.eururo.2016.10.008. Epub 2016 Oct 28.
6
Ensemble forecasting of a continuously decreasing trend in bladder cancer incidence in Taiwan.台湾膀胱癌发病率持续下降趋势的综合预测。
Sci Rep. 2021 Apr 16;11(1):8373. doi: 10.1038/s41598-021-87770-2.
7
Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study.奈梅亨膀胱癌研究中复发性尿路感染与膀胱癌风险
Br J Cancer. 2015 Feb 3;112(3):594-600. doi: 10.1038/bjc.2014.601. Epub 2014 Nov 27.
8
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).患有其他原发性癌症的膀胱癌患者的治疗和预后:瑞典膀胱癌数据库(BladderBaSe)中的一项全国性基于人群的研究。
BJU Int. 2020 Nov;126(5):625-632. doi: 10.1111/bju.15198. Epub 2020 Aug 31.
9
Epidemiology and risk factors of urothelial bladder cancer.尿路上皮膀胱癌的流行病学和危险因素。
Eur Urol. 2013 Feb;63(2):234-41. doi: 10.1016/j.eururo.2012.07.033. Epub 2012 Jul 25.
10
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.尿 UBC 快速检测和 NMP22 检测用于膀胱癌监测与尿细胞学检测的比较:一项前瞻性单中心研究的结果。
Int J Med Sci. 2017 Jul 19;14(9):811-819. doi: 10.7150/ijms.19929. eCollection 2017.

引用本文的文献

1
Predictive value of mitotic figure counts in tumor progression of non-invasive high-grade papillary urothelial carcinoma of the urinary bladder: A retrospective study from a single cancer center.有丝分裂计数在膀胱非侵袭性高级别乳头状尿路上皮癌肿瘤进展中的预测价值:来自单一癌症中心的回顾性研究
Bladder (San Franc). 2025 Jan 27;12(1):e21200026. doi: 10.14440/bladder.2024.0021. eCollection 2025.
2
Single-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan.肌肉浸润性膀胱癌开放性根治性膀胱切除术的单外科医生手术结果:来自阿塞拜疆一家三级中心的经验
Surg Pract Sci. 2025 Jul 3;22:100296. doi: 10.1016/j.sipas.2025.100296. eCollection 2025 Sep.
3

本文引用的文献

1
The global burden of urinary bladder cancer.膀胱癌的全球负担。
Scand J Urol Nephrol Suppl. 2008 Sep(218):12-20. doi: 10.1080/03008880802285032.
2
Epidemiology and genetic susceptibility to bladder cancer.膀胱癌的流行病学与遗传易感性
BJU Int. 2008 Nov;102(9 Pt B):1207-15. doi: 10.1111/j.1464-410X.2008.07961.x.
3
Bilharziasis and bladder cancer: a time trend analysis of 9843 patients.血吸虫病与膀胱癌:对9843例患者的时间趋势分析
Urea Transporters and Their Gene Mutations in Diseases.
疾病中的尿素转运蛋白及其基因突变
Subcell Biochem. 2025;118:127-140. doi: 10.1007/978-981-96-6898-4_7.
4
Assessing the Impact of -2578C>A (rs699947) and -7C>T (rs2010963) Polymorphisms on Bladder Cancer Susceptibility: A Pilot Study.评估-2578C>A(rs699947)和-7C>T(rs2010963)多态性对膀胱癌易感性的影响:一项初步研究。
World J Oncol. 2025 Jun;16(3):295-298. doi: 10.14740/wjon2515. Epub 2025 Jun 14.
5
NEURL1 acts as a candidate suppressor in bladder cancer by down-regulating PDE9A.NEURL1通过下调PDE9A在膀胱癌中作为候选抑制因子发挥作用。
In Vitro Cell Dev Biol Anim. 2025 May 29. doi: 10.1007/s11626-025-01047-w.
6
Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Guérin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study.吡柔比星与卡介苗膀胱内热化疗治疗高危非肌层浸润性膀胱癌患者的比较:一项回顾性研究
BMC Urol. 2025 Apr 9;25(1):81. doi: 10.1186/s12894-025-01773-z.
7
Radical cystectomy for bladder cancer in Sub-Saharan Africa: techniques, challenges, and survival outcomes: a comprehensive review.撒哈拉以南非洲地区膀胱癌根治性膀胱切除术:技术、挑战及生存结果:一项综合综述
BMC Surg. 2025 Apr 8;25(1):143. doi: 10.1186/s12893-025-02887-9.
8
Outcomes of radical cystectomy in a resource-limited setting: a pilot study.资源有限环境下根治性膀胱切除术的结果:一项试点研究。
BMC Urol. 2025 Feb 18;25(1):31. doi: 10.1186/s12894-025-01713-x.
9
Gastric Outlet Obstruction as a First Symptom of a Non-Muscle Invasive Bladder Cancer (NMIBC) Progression-A Case Report.胃出口梗阻作为非肌层浸润性膀胱癌(NMIBC)进展的首发症状——病例报告
Cancer Rep (Hoboken). 2024 Dec;7(12):e70077. doi: 10.1002/cnr2.70077.
10
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered studies.运用多层次研究解析中高危和(极)高危非肌层浸润性膀胱癌的分子异质性
Front Oncol. 2024 Oct 21;14:1424293. doi: 10.3389/fonc.2024.1424293. eCollection 2024.
J Egypt Natl Canc Inst. 2007 Jun;19(2):158-62.
4
[The risk of cancer in the Netherlands].[荷兰的癌症风险]
Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2233-41.
5
Occupational risk factors.职业风险因素。
Scand J Urol Nephrol Suppl. 2008 Sep(218):58-63. doi: 10.1080/03008880802284423.
6
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.欧洲癌症的近期趋势:自20世纪90年代以来17种癌症部位发病率、生存率和死亡率的综合研究方法
Eur J Cancer. 2008 Jul;44(10):1345-89. doi: 10.1016/j.ejca.2007.12.015. Epub 2008 Feb 14.
7
The changing patterns of bladder cancer in Egypt over the past 26 years.过去26年埃及膀胱癌模式的变化
Cancer Causes Control. 2008 May;19(4):421-9. doi: 10.1007/s10552-007-9104-7. Epub 2008 Jan 10.
8
Declining mortality from bladder cancer in Europe.欧洲膀胱癌死亡率呈下降趋势。
BJU Int. 2008 Jan;101(1):11-9. doi: 10.1111/j.1464-410X.2007.07239.x. Epub 2007 Oct 30.
9
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.《1975 - 2002年全国癌症状况年度报告》,重点介绍基于人群的癌症治疗趋势。
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289.
10
British American Tobacco and Formula One motor racing.英美烟草公司与一级方程式赛车。
BMJ. 2004 Jul 10;329(7457):104-6. doi: 10.1136/bmj.329.7457.104.